@article{ab944f5446c44ae5a3f67f85ef6231ee,
title = "Charlson comorbidity index predicts early mortality and overall survival in acute promyelocytic leukemia",
keywords = "Acute promyelocytic leukemia, Age, Comorbidities, Mortality, Overall survival",
author = "Prajwal Dhakal and Elizabeth Lyden and Utsav Joshi and Avantika Pyakuryal and Krishna Gundabolu and Bhatt, {Vijaya Raj}",
note = "Funding Information: Vijaya Raj Bhatt reports participating in Safety Monitoring Committee for Protagonist, and receiving consulting fees from Genentech, Incyte, Servier Pharmaceuticals LLC, and Abbvie, research funding (institutional) from Abbvie, Pfizer, Incyte, Jazz, and National Marrow Donor Program, and drug support (institutional) from Oncoceutics for a trial. There are no conflicts of interest for any other authors. Krishna Gundabolu reports receiving consulting fees from Bayer consumer care, CTI biopharma, BMS, Blueprint Medicines, Jazz Pharmaceuticals, and BioMarin Pharmaceuticals, and research funding (institutional) from Samus therapeutics, Incyte, and Pfizer. There are no conflicts of interest for any other authors. ",
year = "2022",
month = nov,
doi = "10.1016/j.leukres.2022.106927",
language = "English (US)",
volume = "122",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Ltd",
}